Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
FDA directive on anemia drug in kidney disease patients

FDA directive on anemia drug in kidney disease patients

FDA recommends conservative dosing guidelines for ESAs to treat anemia in patients with CKD

FDA recommends conservative dosing guidelines for ESAs to treat anemia in patients with CKD

Maternal MS not linked with poor pregnancy or birth outcomes

Maternal MS not linked with poor pregnancy or birth outcomes

Health Canada grants market authorization for Sanofi-aventis Jevtana to treat prostate cancer

Health Canada grants market authorization for Sanofi-aventis Jevtana to treat prostate cancer

FDA grants Orphan Drug Designation for Accentia's Revimmune to treat two autoimmune diseases

FDA grants Orphan Drug Designation for Accentia's Revimmune to treat two autoimmune diseases

Los Alamos National Lab scientists win three R&D Magazine's 2011 awards

Los Alamos National Lab scientists win three R&D Magazine's 2011 awards

Incivek-combination therapy increases chances of HCV patients achieving viral cure

Incivek-combination therapy increases chances of HCV patients achieving viral cure

MUHC/McGill parasite disease researcher wins CPHA International Public Health Award

MUHC/McGill parasite disease researcher wins CPHA International Public Health Award

Simple non-invasive breath test could accurately detect vitamin B12 deficiency

Simple non-invasive breath test could accurately detect vitamin B12 deficiency

Genomic study identifies MCU that regulates calcium transport into mitochondria

Genomic study identifies MCU that regulates calcium transport into mitochondria

FDA approves NULOJIX

FDA approves NULOJIX

Allos Therapeutics reports results from FOLOTYN pivotal trial against peripheral T-cell lymphoma

Allos Therapeutics reports results from FOLOTYN pivotal trial against peripheral T-cell lymphoma

'Blue baby' study sheds light on basic biology

'Blue baby' study sheds light on basic biology

Bristol-Myers Squibb receives FDA approval for Nulojix to prevent organ rejection after kidney transplant

Bristol-Myers Squibb receives FDA approval for Nulojix to prevent organ rejection after kidney transplant

OrSense presents non-invasive Hb monitor on World Blood Donors Day

OrSense presents non-invasive Hb monitor on World Blood Donors Day

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

Millennium reports results from two MLN9708 ongoing Phase I studies on multiple myeloma

Millennium reports results from two MLN9708 ongoing Phase I studies on multiple myeloma

Incyte announces additional results from ruxolitinib Phase III trial on myelofibrosis

Incyte announces additional results from ruxolitinib Phase III trial on myelofibrosis

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.